Quality without boundaries

Patient wellbeing and safety form the foundation of our operations. We maintain a rigorous pharmacovigilance framework that safeguards against harm and ensures every product we deliver meets the highest standards for safe, effective use.

We commit to quality.

Our founding of almost 50 years ago was based on the aim of making high-quality medicines by promoting an environment where quality is prioritised. This still stands today, with our employees pledging their commitment to ensuring that high-quality defines everything we do, for the patients we serve. 

Maintaining high-quality across Hikma

Quality at scale

Quality is fundamental to supporting a diverse portfolio of more than 825 products supplied across multiple markets and healthcare settings. As patient needs continue to evolve, our teams work to maintain consistent standards across all aspects of product development, manufacturing and supply.

Our global quality organisation collaborates closely with manufacturing, regulatory and commercial teams to maintain strong quality systems, support compliance and drive continuous improvement across our operations.

Excellence across our manufacturing network

We operates 29 manufacturing plants across North America, Europe and the Middle East and North Africa, producing medicines for some of the world's most highly regulated markets. Maintaining consistent quality across this network requires significant expertise, strong governance and ongoing investment in people, facilities and technology.
We are proud to have 13 US FDA-inspected plants and 12 EMA-inspected plants

Protecting patient safety

Our pharmacovigilance team and programmes support the ongoing monitoring of medicines throughout their lifecycle. By working closely with healthcare professionals, regulators and partners, we can identify, assess and respond to potential safety concerns, helping protect patients and maintain confidence in our products.

As our medicines reach millions of patients each year, maintaining a proactive and robust approach to patient safety remains essential to delivering on our purpose.

We all own and commit to quality

Quality is the responsibility of every employee.

Our commitment to ethical conduct and accountability helps reinforce the strong quality environment that underpins our operations. In 2025, 99% of employees completed ethics and compliance training, helping ensure colleagues across the business understand their responsibilities and are equipped to uphold our standards.

Quality has been integral to Hikma since its founding

"Mangers and company leaders are the role models for their employees. Quality attracts quality. If you’re honest, those who work for you will follow your good example.”

Samih Darwazah Founder of Hikma Pharmaceuticals

"I am continually energised by our commitment to quality, which has been a foundational priority since the company’s inception. Our success as a business is built on this commitment, which not only maintains our licence to operate but, more importantly, allows us to continue serving our patients around the world."

Julie Hill SVP, Corporate Quality Compliance and Health & Safety

Key stats
29 manufacturing plants
3 R&D hubs
13 US FDA-inspected plants
12 EMA-inspected plants
222 million Patients treated

*as of February 2025